A patent holder's request for a permanent injunction cannot be denied simply because removing an infringing drug from the market would reduce the number of available treatments, the federal appeals court ruled in a PCSK9 inhibitor patent dispute.
In an Oct. 5 opinion, a three-judge panel of the US Court of Appeals for the Federal Circuit unanimously...




